PDS in the News

Forbes
Tuesday, September 19, 2017

Open, collective innovation such as Project Data Sphere, designed to collate big data and bridge the distant segments of the health care industry, highlight the necessity of innovation in the sector. 

Pharmaceutical Executive
Friday, May 12, 2017

The value of the active comparator arm data can be seen in a series of peer-accepted manuscripts that have been recently published based upon data aggregated within the Project Data Sphere Cancer Research Platform.

In Vivo
Wednesday, May 10, 2017

Project Data Sphere is taking advantage of new IT platforms and the rich target potential in discovery science to press for a larger industry consensus around new ways to release high-value data embedded in years of trials, all for the benefit of cancer patients.

Health Data Management
Tuesday, March 28, 2017
SAS Insights
Monday, March 13, 2017

A new scientific study, using crowdsourced data from multiple pharmaceutical companies, has helped reveal that a simple blood test can be used to tell almost immediately if a treatment is fighting off the disease in prostate cancer patients. Dr. Howard Scher, an oncologist at Memorial Sloan Kettering, led the research that analyzed crowdsourced data from the Project Data Sphere (PDS) initiative. 

National Cancer Institute's Cancer Currents Blog
Monday, February 6, 2017
The Cancer Letter Publications
Friday, January 6, 2017
PharmaVOICE.com
Monday, November 21, 2016

Pages